Developmental Research Program

发展研究计划

基本信息

  • 批准号:
    7715194
  • 负责人:
  • 金额:
    $ 11.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

The Developmental Research Program (DRP) is a critical component of the Leukemia SPORE application; it effectively demands the exploration of new ideas as pilot projects, development of new resources and implementation of new technologies that are the driving elements of translational research. This effort also provides the SPORE investigators with a renewable source of projects that can fully develop and replace existing SPORE projects that have been completed or have not fulfilled specific translational expectations. Rigorous solicitation of developmental proposals, along with a well-defined peer review process will be critical for implementation of an effective DRP. The DRP will seek to fund a broad range oif proposals that will enhance our existing SPORE Projects, from basic science investigation, population science, and innovative approaches toward prevention, diagnosis, and prognosis as well as experimental therapeutics. The Leukemia SPORE Executive Committee has selected Drs. Michael R. Grever and Clara D. Bloomfield to be Co-Leaders of the DRP. These investigators have important leadership positions in the OSUCCC and nationally in the field of leukemia research, with over 50 years of collectively mentoring junior people in this discipline. The DRP proposal provides evidence of our significant effort to support.pilot projects within the DRP, including strong institutional commitment of dollars and space in order to take maximum advantage of new research opportunities. The DRP provides documentation for our advertisement and solicitation plan, with special emphasis on women and minority physicians and scientists to participate in this endeavor. This is exemplified by two woman and two Hispanic minorities leading potential DRP projects. Additionally, our DRP is focused on involving other institutions with expertise to complement the research program in our SPORE as exemplified by two non-OSU DRP projects. The DRP leaders have developed a rigorous yet efficient review process with selection criteria that should prioritize those innovative and feasible applications that show either synergy with existing work and emphasis in areas that will ultimately broaden the scope of our Leukemia SPORE, while again emphasizing the recruitment of women and minorities to the DRP. Finally, the DRP will provide a broad plan for co-mentoring the funded DRP investigators, in order that they obtain input from basic, clinical, and biostatistical leaders, thus optimizing the likelihood of developing the project into a full SPORE project or other nationally funded independent grant.
发展研究计划(DRP)是白血病孢子应用程序的关键组成部分;

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CLARA D BLOOMFIELD其他文献

CLARA D BLOOMFIELD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CLARA D BLOOMFIELD', 18)}}的其他基金

THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE
NCTN 生物样本库和生物样本资源联盟
  • 批准号:
    10172230
  • 财政年份:
    2015
  • 资助金额:
    $ 11.23万
  • 项目类别:
ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie
ITSC​​ 治疗白血病:NCTN 的新型分子策略:“个体化”治疗
  • 批准号:
    9256443
  • 财政年份:
    2014
  • 资助金额:
    $ 11.23万
  • 项目类别:
ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie
ITSC​​ 治疗白血病:NCTN 的新型分子策略:“个体化”治疗
  • 批准号:
    8605704
  • 财政年份:
    2014
  • 资助金额:
    $ 11.23万
  • 项目类别:
OSU as Network Lead Academic Participating Site for the NCI NCTN
OSU 作为 NCI NCTN 网络主导学术参与网站
  • 批准号:
    9025473
  • 财政年份:
    2014
  • 资助金额:
    $ 11.23万
  • 项目类别:
ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie
ITSC​​ 治疗白血病:NCTN 的新型分子策略:“个体化”治疗
  • 批准号:
    8845179
  • 财政年份:
    2014
  • 资助金额:
    $ 11.23万
  • 项目类别:
Molecular Characterization and Risk Stratification of Acute Myeloid Leukemia
急性髓系白血病的分子特征和风险分层
  • 批准号:
    7715168
  • 财政年份:
    2009
  • 资助金额:
    $ 11.23万
  • 项目类别:
Career Development Program
职业发展计划
  • 批准号:
    7715196
  • 财政年份:
    2009
  • 资助金额:
    $ 11.23万
  • 项目类别:
CALGB
加州大学伯克利分校
  • 批准号:
    6513392
  • 财政年份:
    1998
  • 资助金额:
    $ 11.23万
  • 项目类别:
Cancer and Leukemia Group B - The Ohio State University
癌症和白血病 B 组 - 俄亥俄州立大学
  • 批准号:
    7048482
  • 财政年份:
    1998
  • 资助金额:
    $ 11.23万
  • 项目类别:
CALGB
加州大学伯克利分校
  • 批准号:
    2896456
  • 财政年份:
    1998
  • 资助金额:
    $ 11.23万
  • 项目类别:

相似国自然基金

小型类人猿合唱节奏的功能假说——宣 示社会关系(Social bond advertising) ——验证研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目

相似海外基金

SaTC: CORE: Medium: Increasing user autonomy and advertiser and platform responsibility in online advertising
SaTC:核心:中:增加在线广告中的用户自主权以及广告商和平台责任
  • 批准号:
    2318290
  • 财政年份:
    2024
  • 资助金额:
    $ 11.23万
  • 项目类别:
    Continuing Grant
Marketing meaninglessness: critical anthropology of transnational advertising agencies
营销无意义:跨国广告公司的批判人类学
  • 批准号:
    2724869
  • 财政年份:
    2024
  • 资助金额:
    $ 11.23万
  • 项目类别:
    Studentship
Collaborative Research: SaTC: CORE: Medium: Understanding and Combatting Impersonation Attacks and Data Leakage in Online Advertising
协作研究:SaTC:核心:媒介:理解和打击在线广告中的冒充攻击和数据泄露
  • 批准号:
    2247516
  • 财政年份:
    2023
  • 资助金额:
    $ 11.23万
  • 项目类别:
    Continuing Grant
Innovation in Manufacturing to benefit the Marketing & Advertising Industry
制造创新有利于营销
  • 批准号:
    10064566
  • 财政年份:
    2023
  • 资助金额:
    $ 11.23万
  • 项目类别:
    Collaborative R&D
The Impact of Programmatic Advertising on Market Competition
程序化广告对市场竞争的影响
  • 批准号:
    23K18786
  • 财政年份:
    2023
  • 资助金额:
    $ 11.23万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
A Dynamic Analysis of Advertising Interactive Techniques to Gain the Consumer Engagement
获得消费者参与的广告互动技术的动态分析
  • 批准号:
    23K01642
  • 财政年份:
    2023
  • 资助金额:
    $ 11.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Enabling profitable digital advertising for British SMEs with AI-powered multichannel ads brokerage service
通过人工智能驱动的多渠道广告经纪服务,为英国中小企业实现盈利的数字广告
  • 批准号:
    10070962
  • 财政年份:
    2023
  • 资助金额:
    $ 11.23万
  • 项目类别:
    Collaborative R&D
Cross-Platform Advertising Accountability
跨平台广告责任
  • 批准号:
    10071299
  • 财政年份:
    2023
  • 资助金额:
    $ 11.23万
  • 项目类别:
    Collaborative R&D
Improving the accountability of dark advertising on digital platforms
提高数字平台上暗广告的问责制
  • 批准号:
    IE230100647
  • 财政年份:
    2023
  • 资助金额:
    $ 11.23万
  • 项目类别:
    Early Career Industry Fellowships
An AI/ML-powered insight and improvement tool to help bricks and mortar Mission-Led Business (MLBs) to improve advertising, marketing and business performance
一款由 AI/ML 驱动的洞察和改进工具,可帮助实体任务主导型企业 (MLB) 改善广告、营销和业务绩效
  • 批准号:
    10067255
  • 财政年份:
    2023
  • 资助金额:
    $ 11.23万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了